Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GRAL · against 215 other Healthcare companies of similar size
Ranked #49 of 216 · scores higher than 78% of peers · safety percentile 78
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)23 peers with a safety percentile of 70–79, including GRAL · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GRAL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 209 reported | 0.04× | 0.26× | 79% | 33% | |
| BetaLower is better · 217 reported | 2.84 | 0.55 | 0% | 33% | |
| Current ratioHigher is better · 207 reported | 10.95× | 2.76× | 87% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 3.6B USD | 99 | ||
| 4 | 10.1B EUR (≈$11.1B) | 99 | ||
| 5 | 3.1B EUR (≈$3.4B) | 99 | 100 | |
| 45 | 26.5B CNY (≈$3.7B) | 79 | 69 | |
| 46 | 170.4B THB (≈$4.8B) | 79 | 70 | |
| 47 | 3.7B USD | 79 | 24 | |
| 48 | 679.6B INR (≈$8.2B) | 78 | 77 | |
| 49 | 6.2B USD | 78 | 44 | |
| 50 | 81.4B CNY (≈$11.4B) | 77 | 55 | |
| 51 | 28.4B CNY (≈$4.0B) | 77 | 62 | |
| 52 | 3.3B USD | 76 | 39 | |
| 53 | 10.5B USD | 76 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score